Pages that link to "Q44849814"
Jump to navigation
Jump to search
The following pages link to The Efficacy and Safety of Once-Daily Ceftibuten Compared with Co-amoxiclav in the Treatment of Acute Bacterial Sinusitis (Q44849814):
Displaying 13 items.
- Antibiotics for acute maxillary sinusitis in adults (Q24186686) (← links)
- Antibiotics for acute maxillary sinusitis in adults (Q24200440) (← links)
- Antibiotics for acute maxillary sinusitis (Q24242923) (← links)
- Antibiotics for acute maxillary sinusitis (Q24248717) (← links)
- Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults (Q33420344) (← links)
- Clinical and economic considerations in the use of third-generation oral cephalosporins (Q33569088) (← links)
- Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers (Q39779083) (← links)
- Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy (Q40391910) (← links)
- Amoxycillin Clavulanate: an Assessment after 15 Years of Clinical Application (Q41520020) (← links)
- Ceftibuten: A New Expanded-Spectrum Oral Cephalosporin (Q41593676) (← links)
- Antimicrobial treatment in acute maxillary sinusitis: A meta-analysis (Q57892910) (← links)
- Economic evaluation of antibacterials in the treatment of acute sinusitis (Q77801720) (← links)
- Efficacy and tolerability of cefprozil versus amoxicillin/clavulanate for the treatment of adults with severe sinusitis (Q77899303) (← links)